<scp>CircATIC</scp> inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating <scp>RHCG</scp> through sponging <scp>miR‐10‐3p</scp>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR‐10‐3p

Published:2022-03-20 Issue:7 Volume:13 Page:934-946
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Zhang Kai¹^ORCID,Fan Ruitai¹^ORCID,Zhao Deyao¹,Liu Peipei²,Yang Zheng³,Liu Junqi¹,Zhang Song¹,Rao Shilei³,Wang Yang³,Wan Lixin⁴

Affiliation:

1. Department of Radiation Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

2. Department of Respiratory and Critical Care Medicine Nanyang Central Hospital Nanyang Henan China

3. Department of Radiotherapy Nanyang Central Hospital Nanyang Henan China

4. Department of Oncology Nanyang Central Hospital Nanyang Henan China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14326

Reference31 articles.

1. Cancer statistics in China, 2015

2. Esophageal cancer: Risk factors, genetic association, and treatment

3. Epidemiology of esophageal cancer

4. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

5. The Role of Radiotherapy in Localized Esophageal and Gastric Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs in radiotherapy resistance: Roles and therapeutic implications in gastrointestinal cancer;Biomedicine & Pharmacotherapy;2023-05

2. Implications of Esophageal Cancer Susceptibility Gene Testing for Subsequent Treatment;J BIOL REG HOMEOS AG;2023

3. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance;Pharmacological Research;2023-02

4. Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review);Oncology Letters;2023-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3